We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock
ISEE

Delisted

ISEE was delisted on the 10th of July, 2023.

Back to rankings

48 hedge funds and large institutions have $17.3M invested in IVERIC bio, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 17 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

8% less funds holding

Funds holding: 52 → 48 (-4)

18% less capital invested

Capital invested by funds: $21.2M → $17.3M (-$3.91M)

50% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 8

71% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 17

Holders
48
Holders Change
-4
Holders Change %
-7.69%
% of All Funds
1.05%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
5
Reduced
17
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$35.6K
2
Goldman Sachs
Goldman Sachs
New York
+$34.2K
3
Morgan Stanley
Morgan Stanley
New York
+$10.1K
4
Victory Capital Management
Victory Capital Management
Texas
+$6.93K
5
Bank of America
Bank of America
North Carolina
+$5.52K

Top Sellers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
-$335K
2
JP Morgan Chase
JP Morgan Chase
New York
-$176K
3
Deutsche Bank
Deutsche Bank
Germany
-$153K
4
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$109K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$98.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
SEI Investments
26
SEI Investments
Pennsylvania
$31K – – –
Bank of New York Mellon
27
Bank of New York Mellon
New York
$25K – – –
ARTA
28
A.R.T. Advisors
New York
$23K -$4.3K -3,700 -15%
Deutsche Bank
29
Deutsche Bank
Germany
$10K -$153K -131,107 -93%
Victory Capital Management
30
Victory Capital Management
Texas
$7K +$6.93K +5,960 New
Bank of America
31
Bank of America
North Carolina
$6K +$5.52K +4,741 +872%
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
$4K +$853 +733 +27%
PAM
33
Panagora Asset Management
Massachusetts
$3K -$36.1K -31,013 -92%
Citigroup
34
Citigroup
New York
$2K -$2.84K -2,444 -59%
CG
35
Cutler Group
California
$2K – – –
EWM
36
Endurance Wealth Management
Rhode Island
$2K – – –
JP Morgan Chase
37
JP Morgan Chase
New York
$1K -$176K -151,352 -99%
Federated Hermes
38
Federated Hermes
Pennsylvania
$1K -$519 -446 -70%
UBS Group
39
UBS Group
Switzerland
$1K -$233 -200 -29%
AP
40
Atwood & Palmer
Missouri
$1K – – –
BNP Paribas Financial Markets
41
BNP Paribas Financial Markets
France
$46 – – –
SIM
42
Spark Investment Management
New York
– -$68K -52,702 Closed
Charles Schwab
43
Charles Schwab
California
– -$39K -29,361 Closed
Millennium Management
44
Millennium Management
New York
– -$37K -28,207 Closed
Russell Investments Group
45
Russell Investments Group
United Kingdom
– -$37K -28,150 Closed
Wells Fargo
46
Wells Fargo
California
– -$31.6K -27,190 -97%
GF
47
Gabelli Funds
New York
– -$26K -20,000 Closed
Squarepoint
48
Squarepoint
New York
– -$16K -12,557 Closed
KCPG
49
Kavar Capital Partners Group
Kansas
– -$5K -3,500 Closed
WT
50
Whittier Trust
California
– +$62 +53 New
1
2
3

ISEE Hedge Fund Activity: Q3 2019 in Review

48 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q3 2019, worth a combined $17.3M — down 18% from $21.2M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of ISEE and 4 opened new positions — a net loss of 4 holders — while 17 trimmed existing stakes and 5 added.

The largest buyer was Vanguard Group, adding an estimated $35.6K. The largest seller was Stonepine Capital Management, cutting an estimated $335K.

  • 48 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q3 2019, down from 52 in Q2 2019.
  • Funds reported $17.3M of IVERIC bio, Inc. Common Stock stock for Q3 2019, down 18% quarter-over-quarter.
  • 4 funds opened new IVERIC bio, Inc. Common Stock positions in Q3 2019 and 8 closed out, a net change of -4 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q3 2019 was Vanguard Group, an estimated $35.6K added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q3 2019 was Stonepine Capital Management, an estimated $335K sold.

Based on aggregated 13F filings for Q3 2019.